Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/3/2009

host a conference call with a simultaneous webcast, today November 3, 2009, at 5:00 PM Eastern Time, to discuss its third quarter 2009 results. To access the live conference call, U.S. and Canadian participants may dial 800-510-9691; international participants may dial 617-614-3453. The access code for the live call is 62898415. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 52451599. The conference call will also be webcast live and archived on ISTA's website for 30 days at http://www.istavision.com.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5%, Xibrom(TM) (bromfenac ophthalmic solution) 0.09%, Istalol® (timolol maleate ophthalmic solution) 0.5%, and Vitrase® (hyaluronidase injection) are trademarks of ISTA Pharmaceuticals.

Full prescribing information for Bepreve(TM) is available on ISTA Pharmaceuticals' website at http://www.istavision.com/pdf/Bepreve_insert.pdf

Full prescribing information for Xibrom is available on ISTA Pharmaceuticals' website at www.istavision
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...se is available in German . , Whether it,s ...RFID tags (Radio Frequency Identification) are inc...ey make it possible to label objects or goods and ...e appropriate scanner can read and process the dat...xed to goods under production conditions of up to ...
(Date:11/24/2009)... The New York investment bank KTA Capi...has agreed an AU$6.7 mil convertible note private ...private placement was arranged by KTA Capital as N... New York (PRWEB) November ...nk KTA Capital, LLC ("KTA Capital") has ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /P...daq: DCGN ) today announced that it has received n... the company,s common stock will be,suspended as o...d with the,Securities and Exchange Commission, whi...on Nasdaq, unless the company files an appeal to t...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /P...daq: DCGN ) today announced the approval of all of...urt for the District of Delaware,(the "Bankruptcy ...on for,relief under Chapter 11 of the United State..., The orders issued by the Bankruptcy Court al...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...ntext of how business is conducted today, how impo...on,s core mission? , ,Important enough that the ex...IOs. , ,Given all that has transpired in recent ye...n technology implementations, the relationship cle...just the tip of the iceberg, according to prominen...
...hcare and the Vancouver Island Health Authority ...eement under which the authority would purchase 48... GE,s most advanced ultrasound technologies and es...rocesses. , ,Jac Kreut, chair of the VIHA board,...agnosis and faster exams, and reduce the inconveni...
...s month,s meeting of the Wisconsin Innovation Net...e Wisconsin Taxpayers Alliance was asked what si...cing per capita incomes that matched the state ave...ng the state,s taxation and government spending tr...r about high taxes. Instead, the WTA president boi...
Other Biology Technology:Fusion 2007: CEOs say bar is raised for CIOs 2Fusion 2007: CEOs say bar is raised for CIOs 3Fusion 2007: CEOs say bar is raised for CIOs 4Education is fundamental to Milwaukee's growth 2Education is fundamental to Milwaukee's growth 3Education is fundamental to Milwaukee's growth 4
(Date:11/24/2009)... American College of Medical Toxicology (ACMT) hav...ation of the Journal of Medical Toxicology (JMT)...arch 2010. It was previously published by the Uni...f Medical Toxicology , an international, peer-revi...e and practice of medical toxicology. The quarter...
(Date:11/24/2009)... available in Spanish . , The presence of i...inflammatory substances in the blood, hinders the ... research project of the University of Navarra con... the School of Pharmacy. , The project, entitled...n to the control of body weight and inflammation,"...
(Date:11/23/2009)... the Wildlife Conservation Society says that weste... Republic of Congopart of the "mother lode" of mor...coming increasingly threatened by growing humans a...otection of the swamp forests adjacent to the sout...ent surveys confirmed that high densities of the g...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Reinterpretation of proximal colon polyps called hyperplastic in 2001 55266 1Reinterpretation of proximal colon polyps called hyperplastic in 2001 55266 2Not only the gene itself its abnormal regulation can also trigger short stature 55262 1Not only the gene itself its abnormal regulation can also trigger short stature 55262 2Not only the gene itself its abnormal regulation can also trigger short stature 55262 3Worlds last great forest under threat 3A New study 9689 1Worlds last great forest under threat 3A New study 9689 2
...Pharma, Inc., have announced the Food and Drug Adm...r hernia repair that incorporates a biodegradable ...n signals a paradigm shift in the application of b... toward regenerative medicine, in which materials ...ed. , The device consists of a surgical mesh coat...
...that, across human cultures and in most mammals, m...g than females. It,s simple to blame male hormones...ression. But maybe it,s in our genes, too. , Indee...ccording to new research on mice by neuroscientist...he differences in sex chromosomes, XX versus XY, a...
...s in the evolution of bees is how some species dev...Life Sciences associate professor Gro Amdam thinks...oductive traits. , A paper describing Amdam,s exp...ternal reproductive traits," is the cover story of...ional authors include M. Kim Fondrk and Robert Pag...
Other Biology News:FDA approves first medical device using rutgers biomaterial 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2ASU researchers find link between social behavior, maternal traits in bees 2ASU researchers find link between social behavior, maternal traits in bees 3ASU researchers find link between social behavior, maternal traits in bees 4
Rabbit Anti-NFkB p105 / p50, phospho (Ser337) Antibody, Unconjugated from Raybiotech, Inc.
Caspase-3/7 Inhibitor I from Calbiochem
Rat Anti-Vitamin B3 Polyclonal Antibody, Unconjugated from Abcam
Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences
Biology Products: